BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Oncogene Protein V-Akt

Download PDF PDF Version

Image Results

Loading...

Recent Publications on Oncogene Protein V-Akt:

Pubmed Logo
Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function.
Tuberous sclerosis (TSC) is a hamartoma syndrome attributable to mutations...		27th June, 2008
Division of Translational Medicine, Department of Medicine, Brigham and J Neurosci. 2008 May 21;28(21):5422-32.
DOI Direct Link
DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein.
BACKGROUND: C-Myc is a short-lived oncoprotein that is destroyed by...		21st June, 2008
Department of Radiation Toxicology and Oncology, Beijing Institute of Mol Cancer. 2008 Apr 22;7:32.
DOI Direct Link
Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle.
Circulating dehydroepiandrosterone (DHEA) is converted to testosterone or...		20th June, 2008
Graduate School of Comprehensive Human Sciences, University of Tsukuba, Am J Physiol Endocrinol Metab. 2008 May;294(5):E961-8. Epub 2008 Mar 18.
DOI Direct Link
Epigallocatechin-3-O-gallate inhibits TNFalpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells.
Monocyte chemotactic protein-1 (MCP-1) plays a pivotal role in the...		18th June, 2008
Department of Obstetrics and Gynecology, Perinatal Research Centre, Life Sci. 2008 Apr 23;82(17-18):964-8. Epub 2008 Mar 8.
DOI Direct Link
Induction of apoptosis by a stilbene analog involves Bax translocation regulated by p38 MAPK and Akt.
trans-Stilbenes have been reported to induce cytochrome P450 1B1 (CYP1B1)...		12th June, 2008
College of Pharmacy, Chung-Ang University, Seoul, Korea. Arch Pharm Res. 2008 Apr;31(4):438-44. Epub 2008 May 1.
DOI Direct Link

→View more research publications.

BioNews Results for Oncogene Protein V-Akt:

RSS Logo		 BioPortfolio Logo
Akt compositions for enhancing survival of cells
PharmCast:  May 22 2008 3:53AM Matching: oncogene protein v akt

BioPortfolio Ltd. offers e-mail and postal lists for Oncogene Protein V-Akt scientists - we have details of around 43 individuals working on Oncogene Protein V-Akt .


This page has been viewed 67 times
Recent Search Terms used to find this page: diindolylmethane | v-akt | akt | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Oncogene Protein V-Akt across BioPortfolio, or bestselling Oncogene Protein V-Akt books or recently published Oncogene Protein V-Akt books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional